Seeing Is Believing
with an average price target of $3.5. This is a potential upside of $3.5 (0%) from yesterday's end of day stock price of $0.
Recro Pharma's activity chart (see below) currently has 23 price targets and 13 ratings on display.
Analysts average stock forecasts to be materialized ratio is 56.25% with an average time for these price targets to be met of 110 days.
Most recent stock forecast was given by JEFF JOHNSON from BAIRD on 11-Aug-2020. First documented stock forecast 16-Sep-2016.
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
5
$4.21 (532.91%)
18
3 years 7 months 17 days ago
2/4 (50%)
$3.59 (41.69%)
106
Buy
12
$11.21 (1418.99%)
18
3 years 10 months 16 days ago
3/6 (50%)
$7.12 (145.90%)
127
Buy
4 years 4 months 2 days ago
3/3 (100%)
$2.32 (40.35%)
197
Hold
6.73
$5.94 (751.90%)
5 years 3 days ago
1/4 (25%)
$0.98 (17.04%)
10
What is REPH (Recro Pharma) average time for price targets to be met?
Which analyst has the current highest performing score on REPH (Recro Pharma) with a proven track record?
Which analyst has the current lower performing score on REPH (Recro Pharma) with a proven track record?
Which analyst has the most public recommendations on REPH (Recro Pharma)?
Which analyst is the currently most bullish on REPH (Recro Pharma)?
Which analyst is the currently most reserved on REPH (Recro Pharma)?